ML 2-23

ML 2-23 is a PROTAC molecule that selectively induces proteasome-mediated degradation of the BCR-ABL oncoprotein. It serves as a valuable research tool for investigating targeted protein degradation in chronic myeloid leukemia models, both in cellular and animal studies.